Covetrus Inc (CVET)
20.83
+0.02 (+0.10%)
USD |
NASDAQ |
Aug 15, 16:00
20.82
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.916B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -14.17% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.615 |
| Price to Book Value | 1.937 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.697 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
News
Headline
Wire
Time (ET)
Yahoo
07/26 08:00
PR Newswire
07/21 12:49
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 11/04/2022* | 16:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 11/04/2022* | -- | Results | Q3 2022 | -- | 0.27 | -- | |
| 08/04/2022 | -- | Results | Q2 2022 | 0.26 | 0.25 | 1.69% | |
| 05/05/2022 | -- | Results | Q1 2022 | 0.25 | 0.22 | 13.00% | |
| 05/05/2022 | 16:30 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 02/24/2022 | -- | Results | Q4 2021 | 0.26 | 0.24 | 7.16% | |
| 02/24/2022 | 16:30 EST | Earnings Call | Q4 2021 | -- | -- | -- | |
| 11/04/2021 | -- | Results | Q3 2021 | 0.23 | 0.23 | -0.99% |
*Estimated Date/Time
Earnings
Profile
Edit
| Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe and the Asia Pacific (APAC) and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management. |
| URL | https://www.covetrus.com |
| Investor Relations URL | https://ir.covetrus.com/ |
| HQ State/Province | Maine |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Nov. 04, 2022 (est.) |
| Last Earnings Release | Aug. 04, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0.00% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of August 15, 2022.
Fundamentals
| Revenue (TTM) | 4.649B |
| Total Expenses (TTM) | 4.65B |
| Net Income (TTM) | -13.00M |
| Total Assets (Quarterly) | 3.398B |
| Total Liabilities (Quarterly) | 1.871B |
| Shareholders Equity (Quarterly) | 1.505B |
| Cash from Operations (TTM) | 60.00M |
| Cash from Investing (TTM) | -156.00M |
| Cash from Financing (TTM) | -38.00M |
Ratings
Profile
Edit
| Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe and the Asia Pacific (APAC) and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management. |
| URL | https://www.covetrus.com |
| Investor Relations URL | https://ir.covetrus.com/ |
| HQ State/Province | Maine |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Nov. 04, 2022 (est.) |
| Last Earnings Release | Aug. 04, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| CVET Tweets |